Ferrari Serge, Reginster Jean-Yves, Brandi Maria Luisa, Kanis John A, Devogelaer Jean-Pierre, Kaufman Jean-Marc, Féron Jean-Marc, Kurth Andreas, Rizzoli René
Service of Bone Diseases, Department of Internal Medicine Specialties, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva 14, Switzerland.
Bone and Cartilage Metabolism Unit, University of Liège, Liège, Belgium.
Arch Osteoporos. 2016 Dec;11(1):37. doi: 10.1007/s11657-016-0292-1. Epub 2016 Oct 31.
This review provides a critical analysis of currently available approaches to increase bone mass, structure and strength through drug therapy and of possible direct intra-osseous interventions for the management of patients at imminent risk of hip fracture.
Osteoporotic hip fractures represent a particularly high burden in morbidity-, mortality- and health care-related costs. There are challenges and unmet needs in the early prevention of hip fractures, opening the perspective of new developments for the management of osteoporotic patients at imminent and/or at very high risk of hip fracture. Amongst them, preventive surgical intervention needs to be considered.
A European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)/International Osteoporosis Foundation (IOF) working group reviewed the presently available intervention modalities including preventive surgical options for hip fragility. This paper represents a summary of the discussions.
Prevention of hip fracture is currently based on regular physical activity; prevention of falls; correction of nutritional deficiencies, including vitamin D repletion; and pharmacological intervention. However, efficacy of these various measures to reduce hip fractures is at most 50% and may need months or years before becoming effective. To face the challenges of early prevention of hip fractures for osteoporotic patients at imminent and/or at very high risk of hip fracture, preventive surgical intervention needs further investigation.
Preventive surgical intervention needs to be appraised for osteoporotic patients at imminent and/or at very high risk of hip fracture.
本综述对目前通过药物治疗增加骨量、改善骨结构和增强骨强度的可用方法,以及对即将发生髋部骨折风险的患者进行可能的直接骨内干预措施进行了批判性分析。
骨质疏松性髋部骨折在发病率、死亡率和医疗保健相关费用方面负担尤为沉重。在髋部骨折的早期预防方面存在挑战和未满足的需求,这为管理处于即将发生和/或极高髋部骨折风险的骨质疏松患者带来了新的发展前景。其中,预防性手术干预需要被考虑。
欧洲骨质疏松、骨关节炎和肌肉骨骼疾病临床与经济学会(ESCEO)/国际骨质疏松基金会(IOF)工作组回顾了目前可用的干预方式,包括针对髋部脆性的预防性手术选择。本文是讨论内容的总结。
目前髋部骨折的预防基于规律的体育活动、预防跌倒、纠正营养缺乏(包括补充维生素D)以及药物干预。然而,这些不同措施减少髋部骨折的疗效至多为50%,且可能需要数月或数年才会生效。为应对对处于即将发生和/或极高髋部骨折风险的骨质疏松患者进行髋部骨折早期预防的挑战,预防性手术干预需要进一步研究。
对于处于即将发生和/或极高髋部骨折风险的骨质疏松患者,需要对预防性手术干预进行评估。